Virbac Group, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1968, Virbac has established itself as a leader in animal health, focusing on the development and production of innovative veterinary products and services.
The company’s core offerings include vaccines, antibiotics, and antiparasitics, all designed to enhance the health and well-being of pets and livestock. What sets Virbac apart is its commitment to research and development, ensuring that its products meet the highest standards of efficacy and safety.
With a strong market position, Virbac has achieved significant milestones, including numerous regulatory approvals and a robust global distribution network, solidifying its reputation as a trusted partner in animal healthcare.
-5 vs industry average
Virbac group’s score of 34 is lower than 48% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Virbac group?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Virbac group's reported carbon emissions
Virbac, headquartered in France and operating in the Pharmaceutical Preparation Manufacturing industry, has outlined significant climate commitments. For 2022, the company reported Scope 1 emissions of approximately 23,727,000 kg CO2e. In 2021, their Scope 1 emissions were approximately 20,814,000 kg CO2e, and in 2020, they were approximately 21,007,000 kg CO2e. Earlier data from 2014 indicates more comprehensive reporting, with Scope 1 emissions at approximately 19,186,000 kg CO2e, Scope 2 emissions at approximately 15,014,000 kg CO2e, and Scope 3 emissions at approximately 6,818,000 kg CO2e, including approximately 4,985,000 kg CO2e for purchased goods and services.
Virbac has established a clear reduction target: the company intends to reduce its Scope 1 and Scope 2 CO2 emissions in absolute terms by 30% by 2030, using 2020 as the baseline year. This target is considered near-term and is set to be achieved by 2030. The company is currently on track to meet its five-year target for Scope 1 emissions.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Virbac group’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Virbac group
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project